Scott Gawel, Principal Accounting Officer of NVIDIA Corporation, filed a statement of changes in beneficial ownership on September 18, 2026, disclosing a tax-withholding transaction tied to the vesting of restricted stock units on September 16, 2026.
Timothy S. Teter, Executive Vice President, General Counsel and Secretary of NVIDIA Corp (NASDAQ:NVDA), filed a Form 4 on September 18, 2026, disclosing a share disposition on September 16, 2026, related to the vesting of restricted stock units.
Donna Blackman, Chief Financial Officer of Stride, Inc. (NYSE:LRN), filed a Form 4 on September 18, 2026, disclosing three transactions in common stock that occurred on September 16, 2026, related to the vesting of equity awards and the withholding of shares for tax purposes.
A Form 4 filed with the SEC on September 18, 2026 discloses that Jeffrey A. Graves, President and CEO of 3D Systems Corp (NYSE:DDD), sold 42,686 shares of common stock on September 17, 2026 at a weighted average price of $3.55 per share.
Phyllis B. Nordstrom, EVP, CFO and CAO of 3D Systems Corp, filed a Form 4 on September 18, 2026, disclosing the sale of 30,000 shares of common stock on September 17, 2026.
Todd Goldthwaite, Managing Director at Stride, Inc. (NYSE:LRN), filed a Form 4 on September 18, 2026, disclosing three common stock transactions on September 16, 2026, related to the vesting of a performance award and a restricted stock right.
Kal Iyer, VP of Engineering at Wealthfront Corp (NASDAQ:WLTH), filed a Form 4 on September 18, 2026, reporting the sale of 26,738 shares of common stock on September 17, 2026, pursuant to a Rule 10b5-1 trading plan.
Lauren Lin, CLO, CCO and Secretary of Wealthfront Corp (NASDAQ:WLTH), filed a Form 4 on September 18, 2026, reporting the sale of 4,574 shares of common stock on September 17, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
Julien Wetterwald, Chief Technology Officer of Wealthfront Corp (NASDAQ:WLTH), filed a Form 4 on September 18, 2026, reporting the sale of 26,138 shares of common stock on September 17, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
Edward Carr, Chief Accounting Officer of Dianthus Therapeutics, Inc. (NASDAQ:DNTH), filed a Form 4 on September 18, 2026, disclosing the exercise of a stock option and the sale of common stock on September 17, 2026, pursuant to a Rule 10b5-1 trading plan.